1. Home
  2. LCID vs WGS Comparison

LCID vs WGS Comparison

Compare LCID & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lucid Group Inc.

LCID

Lucid Group Inc.

N/A

Current Price

$4.20

Market Cap

3.2B

ML Signal

N/A

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

N/A

Current Price

$85.27

Market Cap

2.7B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
LCID
WGS
Founded
2007
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Retail: Computer Software & Peripheral Equipment
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.7B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
LCID
WGS
Price
$4.20
$85.27
Analyst Decision
Hold
Strong Buy
Analyst Count
7
7
Target Price
$15.71
$120.71
AVG Volume (30 Days)
10.1M
439.7K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
62.37
EPS
N/A
N/A
Revenue
$595,271,000.00
$427,539,000.00
Revenue This Year
$71.67
$29.98
Revenue Next Year
$89.72
$25.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
39.97
52 Week Low
$2.37
$32.21
52 Week High
$25.22
$170.87

Technical Indicators

Market Signals
Indicator
LCID
WGS
Relative Strength Index (RSI) 28.99 58.45
Support Level $2.37 $81.37
Resistance Level $6.85 $94.82
Average True Range (ATR) 0.35 4.17
MACD -0.07 -0.74
Stochastic Oscillator 6.61 39.84

Price Performance

Historical Comparison
LCID
WGS

About LCID Lucid Group Inc.

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design, which led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: